Residual Viral Replication during Antiretroviral Therapy Boosts Human Immunodeficiency Virus Type 1-Specific CD8(+) T-Cell Responses in Subjects Treated Early after Infection

Similar Items

• Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy
  od: Ogg, G. S., i dr.
  Izdano: (1999)
• Phenotypic, Functional, and Kinetic Parameters Associated with Apparent T-Cell Control of Human Immunodeficiency Virus Replication in Individuals with and without Antiretroviral Treatment
  od: Emu, Brinda, i dr.
  Izdano: (2005)
• Use of Real-Time PCR and Molecular Beacons To Detect Virus Replication in Human Immunodeficiency Virus Type 1-Infected Individuals on Prolonged Effective Antiretroviral Therapy
  od: Lewin, S. R., i dr.
  Izdano: (1999)
• Emergence of Polyfunctional CD8(+) T Cells after Prolonged Suppression of Human Immunodeficiency Virus Replication by Antiretroviral Therapy
  od: Rehr, Manuela, i dr.
  Izdano: (2008)
• Interleukin-8 Stimulates Human Immunodeficiency Virus Type 1 Replication and Is a Potential New Target for Antiretroviral Therapy
  od: Lane, Brian R., i dr.
  Izdano: (2001)